Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0002710 | negative regulation of T cell mediated immunity | 9/2508 | 19/18670 | 0.0003629 | 0.003467 | 0.002331 | 9 | RABC85 | |
BP | GO:0010888 | negative regulation of lipid storage | 9/2508 | 19/18670 | 0.0003629 | 0.003467 | 0.002331 | 9 | RABC85 | |
BP | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 9/2508 | 19/18670 | 0.0003629 | 0.003467 | 0.002331 | 9 | RABC85 | |
BP | GO:0008064 | regulation of actin polymerization or depolymerization | 41/2508 | 179/18670 | 0.0003644 | 0.003476 | 0.002337 | 41 | RABC85 | |
BP | GO:0110111 | negative regulation of animal organ morphogenesis | 13/2508 | 35/18670 | 0.0003697 | 0.003521 | 0.002367 | 13 | RABC85 | |
BP | GO:0043010 | camera-type eye development | 64/2508 | 314/18670 | 0.0003743 | 0.003559 | 0.002393 | 64 | RABC85 | |
BP | GO:0009895 | negative regulation of catabolic process | 63/2508 | 308/18670 | 0.000375 | 0.00356 | 0.002393 | 63 | RABC85 | |
BP | GO:0009062 | fatty acid catabolic process | 28/2508 | 108/18670 | 0.0003763 | 0.003567 | 0.002398 | 28 | RABC85 | |
BP | GO:0070228 | regulation of lymphocyte apoptotic process | 17/2508 | 53/18670 | 0.0003793 | 0.003587 | 0.002412 | 17 | RABC85 | |
BP | GO:0046328 | regulation of JNK cascade | 42/2508 | 185/18670 | 0.0003796 | 0.003587 | 0.002412 | 42 | RABC85 | |
BP | GO:0032872 | regulation of stress-activated MAPK cascade | 51/2508 | 237/18670 | 0.0003834 | 0.003618 | 0.002432 | 51 | RABC85 | |
BP | GO:0007623 | circadian rhythm | 46/2508 | 208/18670 | 0.0003847 | 0.003622 | 0.002435 | 46 | RABC85 | |
BP | GO:1905952 | regulation of lipid localization | 37/2508 | 157/18670 | 0.000385 | 0.003622 | 0.002435 | 37 | RABC85 | |
BP | GO:0007254 | JNK cascade | 47/2508 | 214/18670 | 0.0003946 | 0.003693 | 0.002483 | 47 | RABC85 | |
BP | GO:0010631 | epithelial cell migration | 70/2508 | 351/18670 | 0.0003953 | 0.003693 | 0.002483 | 70 | RABC85 | |
BP | GO:0030225 | macrophage differentiation | 15/2508 | 44/18670 | 0.0003961 | 0.003693 | 0.002483 | 15 | RABC85 | |
BP | GO:0035307 | positive regulation of protein dephosphorylation | 15/2508 | 44/18670 | 0.0003961 | 0.003693 | 0.002483 | 15 | RABC85 | |
BP | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 15/2508 | 44/18670 | 0.0003961 | 0.003693 | 0.002483 | 15 | RABC85 | |
BP | GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 15/2508 | 44/18670 | 0.0003961 | 0.003693 | 0.002483 | 15 | RABC85 | |
BP | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 12/2508 | 31/18670 | 0.0003976 | 0.003702 | 0.002489 | 12 | RABC85 | |
BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 30/2508 | 119/18670 | 0.000399 | 0.00371 | 0.002494 | 30 | RABC85 | |
BP | GO:0042093 | T-helper cell differentiation | 18/2508 | 58/18670 | 0.0004071 | 0.003774 | 0.002537 | 18 | RABC85 | |
BP | GO:0061900 | glial cell activation | 18/2508 | 58/18670 | 0.0004071 | 0.003774 | 0.002537 | 18 | RABC85 | |
BP | GO:0030832 | regulation of actin filament length | 41/2508 | 180/18670 | 0.0004118 | 0.003807 | 0.00256 | 41 | RABC85 | |
BP | GO:0006997 | nucleus organization | 32/2508 | 130/18670 | 0.000412 | 0.003807 | 0.00256 | 32 | RABC85 | |
BP | GO:0008286 | insulin receptor signaling pathway | 34/2508 | 141/18670 | 0.0004166 | 0.003844 | 0.002585 | 34 | RABC85 | |
BP | GO:0060349 | bone morphogenesis | 29/2508 | 114/18670 | 0.0004209 | 0.003878 | 0.002607 | 29 | RABC85 | |
BP | GO:0006605 | protein targeting | 83/2508 | 432/18670 | 0.0004241 | 0.003902 | 0.002623 | 83 | RABC85 | |
BP | GO:1904377 | positive regulation of protein localization to cell periphery | 19/2508 | 63/18670 | 0.0004267 | 0.00392 | 0.002635 | 19 | RABC85 | |
BP | GO:0030308 | negative regulation of cell growth | 42/2508 | 186/18670 | 0.0004277 | 0.003924 | 0.002638 | 42 | RABC85 |